Based on the provided document, here's a breakdown of the vulnerability information related to CVE-2023-21923:

**1. Verification:**
   - The document is an Oracle Critical Patch Update Advisory for April 2023 and lists CVE-2023-21923 as one of the addressed vulnerabilities.
   - The affected product is specified as "Oracle Health Sciences InForm".

**2. Vulnerability Details:**

   - **Root Cause:** The document doesn't specify the root cause.
   - **Weaknesses:** The document states, "Core" is vulnerable and the exploit vector is "HTTP".  Further details are not disclosed.
   - **Impact of Exploitation:**  Successful exploitation could lead to a compromise of "High" confidentiality, "High" integrity, and "Low" availability of the InForm system.
   - **Attack Vectors:** The attack vector is via HTTP.
   - **Required Attacker Capabilities/Position:** The attacker must have network access to the InForm system. It appears that authentication is not required, but additional info on authentication is not given.

**Summary:**

CVE-2023-21923 is a vulnerability within the "Core" component of "Oracle Health Sciences InForm." An unauthenticated remote attacker could potentially exploit this vulnerability through the HTTP protocol and achieve high impact to confidentiality, high impact to integrity, and low impact to availability.

**Additional Notes:**
- The document emphasizes the importance of applying the security patches as soon as possible.
- It provides links to the specific patch availability document for the affected products.
- It mentions that additional third-party patches may be included.
- This document serves as a high-level advisory, with detailed information likely residing in the linked support documents.